Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

Participants in an IFS PTSD-SUD (substance use disorder) intervention experienced reduced PTSD symptoms and cravings, making it a promising public health treatment option.

Ryan Paige has called Biddeford home his entire life. He grew up in the city, attended its schools and spent time with ...

Nearly 50 million people in the United States struggle with substance use disorders, and nearly three in four use more than one substance. People with polysubstance use disorders are more likely than ...

In February, the Louisiana Department of Health launched a new era of person-centered care for mothers affected by substance use disorder with the announcement of 11 inaugural Project M.O.M. (Maternal ...

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be ...

In 524,817 adults with T2D, GLP-1 RA use was associated with lower incident alcohol, cocaine, cannabis, opioid, and nicotine ...

Substance use disorders are rarely, if ever, isolated concerns. Substance use is often a response to unaddressed mental health challenges, trauma, and unmet needs, and should be treated as such.

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

Substance use disorder makes it hard to stop using substances even when they're harmful. Using the term "substance use disorder" helps separate the person from the treatable illness. Substance use ...

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some ...

Polysubstance use disorder is a mental health condition in which someone uses more than one substance at the same time or within a short period of time, despite a pattern of negative effects.